Sarepta Avoids IP Claims As Judge Finds UPenn Patent Invalid
A Delaware judge found a gene therapy patent at the center of an infringement suit against Sarepta, brought by the University of Pennsylvania, was ineligible for patent protection because the claims...To view the full article, register now.
Already a subscriber? Click here to view full article